Impact of caloric restriction on the Wnt/β-catenin pathway in the hippocampus and cortex of a Kindled rat model
DOI:
https://doi.org/10.15584/ejcem.2025.1.15Keywords:
caloric restriction, drug-resistant epilepsy, epilepsy, Wnt/β-cateninAbstract
Introduction and aim. Epilepsy is a common neurological disorder, and despite numerous treatment options, approximately 30% of patients have drug-resistant epilepsy. This situation prompts the exploration of alternative treatments such as caloric restriction (CR), whose mechanisms of antiepileptic action need to be fully elucidated. One of the key overactivated pathways in epilepsy is the Wnt/β-catenin pathway.
Material and methods. To explore the potential regulatory effects of CR on this pathway, we conducted a study using twenty-eight male Wistar rats divided into four groups (7 animals each): Control, Sham (20% CR), kindling ad libitum (KAL), and kindling with CR (KCR). Caloric restriction rats received 80% of their daily food intake based on body weight, compared to those fed ad libitum. The kindling model was achieved by the introduction of an electrode in the basolateral nucleus of the amygdala. Immunofluorescence and Western blot techniques were used for the analysis of protein levels (Wnt, β-catenin, GSK3β, and cyclin D) in the frontal cortex and hippocampus.
Results. Electroencephalographically and behaviorally, the KCR group exhibited a shorter duration of seizures and an increased behavioral threshold compared to the KAL group. Protein analysis revealed an increase in Wnt pathway proteins (Wnt, β-catenin, and cyclin D) in the KAL group compared to the control group. In contrast, CR reduced protein levels in animals that were induced to kindling.
Conclusion. These findings suggest that CR may exert its antiepileptic effects through the regulation of the Wnt pathway by inhibiting its activity in the hippocampus and cortex of kindled rats.
Downloads
References
Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-482. doi: 10.1111/epi.12550
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512-521. doi: 10.1111/epi.13709
Rugg-Gunn F, Miserocchi A, McEvoy A. Epilepsy surgery. Pract Neurol. 2020;20(1):4-14. doi: 10.1136/practneurol-2019-002192
Greene AE, Todorova MT, McGowan R, Seyfried TN. Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia. 2001;42(11):1371-1378. doi: 10.1046/j.1528-1157.2001.17601.x
Koh S, Dupuis N, Auvin S. Ketogenic diet and Neuroin-flammation. Epilepsy Res. 2020;167:106454. doi: 10.1016/j.eplepsyres.2020.106454
Barzegar M, Afghan M, Tarmahi V, Behtari M, Rahimi Khamaneh S, Raeisi S. Ketogenic diet: overview, types, and possible anti-seizure mechanisms. Nutr Neurosci. 2021;24(4):307-316. doi: 10.1080/1028415X.2019.1627769
Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia. 2007;48(1):43-58. doi: 10.1111/j.1528-1167.2007.00915.x
Olson CA, Vuong HE, Yano JM, Liang QY, Nusbaum DJ, Hsiao EY. The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet. Cell. 2018;173(7):1728-1741.e13. doi: 10.1016/j.cell.2018.04.027
Wells RG, Neilson LE, McHill AW, Hiller AL. Dietary fasting and time-restricted eating in Huntington’s disease: therapeutic potential and underlying mechanisms. Transl Neurodegener. 2024;13(1):17. doi: 10.1186/s40035-024-00406-z
Vatashchuk MV, Hurza VV, Stefanyshyn N, et al. Impact of caloric restriction on oxidative stress and key glycolytic enzymes in the cerebral cortex, liver and kidney of old and middle-aged mice. Neuropharmacology. 2024;247:109859. doi: 10.1016/j.neuropharm.2024.109859
Benfato ID, Quintanilha ACS, Henrique JS, et al. Long-term calorie restriction prevented memory impairment in middle-aged male mice and increased a marker of DNA oxidative stress in hippocampal dentate gyrus. Neurobiol Learn Mem. 2024;209:107902. doi: 10.1016/j.nlm.2024.107902
Taciak B, Pruszynska I, Kiraga L, Bialasek M, Krol M. Wnt signaling pathway in development and cancer. J Physiol Pharmacol. 2018;69(2). doi: 10.26402/jpp.2018.2.07
Nong J, Kang K, Shi Q, Zhu X, Tao Q, Chen YG. Phase separation of Axin organizes the β-catenin destruction complex. J Cell Biol. 2021;220(4):e202012112. doi: 10.1083/jcb.202012112
Jung YS, Park JI. Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex. Exp Mol Med. 2020;52(2):183-191. doi: 10.1038/s12276-020-0380-6
Vallée A, Lecarpentier Y, Vallée JN. Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs. Cells. 2019;8(7):726. doi: 10.3390/cells8070726
Huang C, Fu XH, Zhou D, Li JM. The Role of Wnt/β-Catenin Signaling Pathway in Disrupted Hippocampal Neurogenesis of Temporal Lobe Epilepsy: A Potential Therapeutic Target? Neurochem Res. 2015;40(7):1319-1332. doi: 10.1007/s11064-015-1614-1
Ramakrishna K, Nalla LV, Naresh D, et al. WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective. Diseases. 2023;11(3). doi: 10.3390/diseases11030089
Kang H. Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 2021;18:17. doi: 10.3352/jeehp.2021.18.17 Nutrition. In: The Laboratory Rat. Academic Press; 1979:123-152. doi: 10.1016/B978-0-12-074901-0.50013-7
Azarbar A, McIntyre DC, Gilby KL. Caloric restriction alters seizure disposition and behavioral profiles in seizure-prone (fast) versus seizure-resistant (slow) rats. Behav Neurosci. 2010;124(1):106-114. doi: 10.1037/a0018307
Goddard GV, McIntyre DC, Leech CK. A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol. 1969;25(3):295-330. doi: 10.1016/0014-4886(69)90128-9
Rubio C, Rosiles-Abonce A, Trejo-Solis C, et al. Increase Signaling of Wnt/β-Catenin Pathway and Presence of Apoptosis in Cerebellum of Kindled Rats. CNS Neurol Disord Drug Targets. 2017;16(7):772-780. doi: 10.2174/1871527316666170117114513
Hodges SL, Lugo JN. Wnt/β-catenin signaling as a potential target for novel epilepsy therapies. Epilepsy Res. 2018;146:9-16. doi: 10.1016/j.eplepsyres.2018.07.002
Madsen TM, Newton SS, Eaton ME, Russell DS, Duman RS. Chronic electroconvulsive seizure up-regulates beta-catenin expression in rat hippocampus: role in adult neurogenesis. Biol Psychiatry. 2003;54(10):1006-1014. doi: 10.1016/s0006-3223(03)00700-5
Qu Z, Su F, Qi X, et al. Wnt/β-catenin signalling pathway mediated aberrant hippocampal neurogenesis in kainic acid-induced epilepsy. Cell Biochem Funct. 2017;35(7):472-476. doi: 10.1002/cbf.3306
Yang J, Zhang X, Wu Y, et al. Wnt/β-catenin signaling mediates the seizure-facilitating effect of postischemic reactive astrocytes after pentylenetetrazole-kindling. Glia. 2016;64(6):1083-1091. doi: 10.1002/glia.22984
Stamos JL, Weis WI. The β-catenin destruction complex. Cold Spring Harb Perspect Biol. 2013;5(1):a007898. Doi: 10.1101/cshperspect.a007898
Aourz N, Serruys ASK, Chabwine JN, et al. Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy. ACS Chem Neurosci. 2019;10(4):1992-2003. doi: 10.1021/acschemneuro.8b00281
Busceti CL, Biagioni F, Aronica E, et al. Induction of the Wnt inhibitor, Dickkopf-1, is associated with neurodegeneration related to temporal lobe epilepsy. Epilepsia. 2007;48(4):694-705. doi: 10.1111/j.1528-1167.2007.01055.x
Gómez Sintes R. Consecuencias neurológicas de la inhibición sostenida de GSK-3 en cerebro adulto. Universidad Autónoma de Madrid; 2009. https://repositorio.uam.es/handle/10486/3557. Accessed May 8, 2024.
Song L, Zhou T, Jope RS. Lithium facilitates apoptotic signaling induced by activation of the Fas death domain-containing receptor. BMC Neurosci. 2004;5:20. doi: 10.1186/1471-2202-5-20
Tripathi PN, Lodhi A, Rai SN, et al. Review of Pharmacotherapeutic Targets in Alzheimer’s Disease and Its Management Using Traditional Medicinal Plants. Degener Neurol Neuromuscul Dis. 2024;14:47-74. doi: 10.2147/DNND.S452009
Inoki K, Ouyang H, Zhu T, et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell. 2006;126(5):955-968. doi: 10.1016/j.cell.2006.06.055
Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol. 2002;4(9):648-657. doi: 10.1038/ncb839
Potter WB, O’Riordan KJ, Barnett D, et al. Metabolic regulation of neuronal plasticity by the energy sensor AMPK. PLoS One. 2010;5(2):e8996. doi: 10.1371/journal.pone.0008996
Noma A. ATP-regulated K+ channels in cardiac muscle. Nature. 1983;305(5930):147-148. doi: 10.1038/305147a0
Paz C, Gutiérrez-Baeza F, Bazán-Perkins B. Transection of the superior cerebellar peduncle interferes with the onset and duration of generalized seizures induced by amygdaloid kindling. Brain Res. 1991;558(1):90-92. doi: 10.1016/0006-8993(91)90718-b
Fasen K, Beck H, Elger CE, Lie AA. Differential regulation of cadherins and catenins during axonal reorganization in the adult rat CNS. J Neuropathol Exp Neurol. 2002;61(10):903-913. doi: 10.1093/jnen/61.10.903
Theilhaber J, Rakhade SN, Sudhalter J, et al. Gene expression profiling of a hypoxic seizure model of epilepsy suggests a role for mTOR and Wnt signaling in epileptogenesis. PLoS One. 2013;8(9):e74428. doi: 10.1371/journal.pone.00744287
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
